News Breaks |
|
|
| October 4, 2012 |
| 08:06 EDT |  | REGN | Regeneron price target raised to $175 from $150 at RW Baird
Baird raised its price target on Regeneron following a bullish survey for its Eylea drug. The firm believes guidance could be raised and raised its estimates ahead of Q3 results. Shares are Outperform rated. |
|
|
News For REGN From The Last 14 Days Check below for free stories on REGN the last two weeks. |
|
|
| May 24, 2013 |
| 11:44 EDT |  | REGN | Stocks with call strike movement; NFLX REGN
Netflix (NFLX) June 255 call option implied volatility increased 1% to 44, Regeneron (REGN) September 300 call option implied volatility decreased 2% to 43 according to IVolatility. |
|
| May 22, 2013 |
| 12:25 EDT | | REGN | Stocks with call strike movement; GME REGN
 Subscribe for More Information |
|
| May 20, 2013 |
| 19:01 EDT |  | REGN | On The Fly: After Hours Movers
Subscribe for More Information |
|
| 17:26 EDT | | REGN | Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information |
|
| 17:20 EDT | | REGN | Regeneron,, Bayer, Genentech resolve certain patent disputes
Subscribe for More Information |
|
| 07:28 EDT |  | REGN | American Thoracic Society to hold a conference
Subscribe for More Information |
|
| May 17, 2013 |
| 10:07 EDT |  | REGN | On The Fly: Analyst Initiation Summary
Subscribe for More Information |
|
| 07:16 EDT | | REGN | Regeneron initiated with a Neutral at UBS
Subscribe for More Information |
|
| 06:33 EDT | | REGN | American Thoracic Society to hold a conference
Subscribe for More Information |
|
| May 15, 2013 |
| 05:39 EDT | | REGN | Sanofi, Regeneron announce patient enrollment in two Phase 3 trials
Subscribe for More Information |
| |
| May 14, 2013 |
| 07:34 EDT | | REGN | Regeneron outlook positive, says RBC Capital
Subscribe for More Information |
|
|
|
|
|
